Signant Health, formed in 2018, is the evidence generation company that supports life sciences organizations by digitally enabling clinical trials and generating high-quality data. The company provides a comprehensive suite of eClinical solutions designed to modernize the clinical trial process for sponsors, sites, and patients. Its technology platforms include electronic Clinical Outcome Assessment (eCOA), Electronic Data Capture (EDC), Randomization and Trial Supply Management (RTSM), eConsent, patient engagement apps, telemedicine, and clinical supply chain software.
These products are integrated into the SmartSignals ecosystem, which combines technology, scientific expertise, and operational support. The company's scale is significant; its solutions have contributed to hundreds of novel drug approvals and supported 25% of all FDA and EMA approvals from 2021 to 2024. Signant Health operates in more than 90 countries.
The company's focus is on meeting patients where they are and reimagining the path to proof in clinical research. While established in its current form via a 2018 merger, the organization draws on over two decades of collective experience in the clinical trials sector. Its work spans the pharmaceutical and life sciences verticals, aiming to improve trial efficiency and data quality worldwide.
